Endocrine Abstracts

Background: Type 1 diabetes mellitus is an autoimmune condition resulting in insulin deficiency, causing both long and short term complications. The Diabetes Control and Complications Trial (DCCT) demonstrated that tight glycaemic control and consequent lower HbA1c values reduced the risk of long-term complications. This can be achieved using multiple daily injections (MDI) or newer continuous subcutaneous insulin infusion (CSII) therapy. This is recommended by NICE for those ...